A Multicenter, Prospective, Randomized, Open-label Study to Compare the Efficacy, Safety, and Tolerability of BOTOX® and Topiramate for Headache Prophylaxis in Adults With Chronic Migraine

Trial Profile

A Multicenter, Prospective, Randomized, Open-label Study to Compare the Efficacy, Safety, and Tolerability of BOTOX® and Topiramate for Headache Prophylaxis in Adults With Chronic Migraine

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs Botulinum toxin A (Primary) ; Topiramate
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms FORWARD
  • Sponsors Allergan
  • Most Recent Events

    • 11 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 06 Sep 2017 According to an Allergan media release, data from the study will be presented at the upcoming 18th Congress of the International Headache Society (IHC2017).
    • 10 Oct 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top